Zobrazeno 1 - 10
of 128
pro vyhledávání: '"LMW-heparin"'
Autor:
Maria Ennemoser, Julia Rieger, Eva Muttenthaler, Tanja Gerlza, Kurt Zatloukal, Andreas J. Kungl
Publikováno v:
Biomedicines, Vol 10, Iss 1, p 49 (2021)
As with many other pathogens, SARS-CoV-2 cell infection is strongly dependent on the interaction of the virus-surface Spike protein with the glycosaminoglycans of target cells. The SARS-CoV-2 Spike glycoprotein was previously shown to interact with c
Externí odkaz:
https://doaj.org/article/59645318dcce4a2b8e436863015fc601
Autor:
Maria Ennemoser, Julia Rieger, Eva Muttenthaler, Tanja Gerlza, Kurt Zatloukal, Andreas J. Kungl
Publikováno v:
Biomedicines, Vol 10, Iss 49, p 49 (2022)
Biomedicines
Biomedicines; Volume 10; Issue 1; Pages: 49
Biomedicines
Biomedicines; Volume 10; Issue 1; Pages: 49
As with many other pathogens, SARS-CoV-2 cell infection is strongly dependent on the interaction of the virus-surface Spike protein with the glycosaminoglycans of target cells. The SARS-CoV-2 Spike glycoprotein was previously shown to interact with c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4557e2acf68c5938221a439432018cf0
https://www.mdpi.com/2227-9059/10/1/49
https://www.mdpi.com/2227-9059/10/1/49
Autor:
Thomas W. Stief
Publikováno v:
Drug Target Insights, Vol 1, Pp 6-11 (2006)
Background: The contact phase of coagulation is of physiologic/pathophysiologic importance, whenever unphysiologic polynegative substances such as cell fragments (microparticles) get in contact with blood. There are several clinically used inhibitors
Externí odkaz:
https://doaj.org/article/b5323c27652348f8bd1f7827df176d6d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Thomas W. Stief
Publikováno v:
Drug Target Insights, Vol 1, Iss 1 (2006)
Abstract non disponibile
Externí odkaz:
https://doaj.org/article/fd055fcb4a894ce4a3361e343c6e6c14
Publikováno v:
医療工学雑誌. 3:33-36
Heparin and low molecular weight heparin have been standard as anticoagulant on emodialysis ,to inhibit the blood coagulation in the blood circuit. Heparin is low price and good anticoagulant. But heparin itself has no effect of anticoagulant, it fun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::7dea1ffaa7c2a48e4e406d678bd67ab5
http://harp.lib.hiroshima-u.ac.jp/hirokoku-u/metadata/5551
http://harp.lib.hiroshima-u.ac.jp/hirokoku-u/metadata/5551
Publikováno v:
医療工学雑誌 = Journal of Medical Engineering. 3:33-36
Heparin and low molecular weight heparin have been standard as anticoagulant on emodialysis ,to inhibit the blood coagulation in the blood circuit. Heparin is low price and good anticoagulant. But heparin itself has no effect of anticoagulant, it fun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=jairo_______::bb6e3da9b1bfedac63e34620c1114bad
http://id.nii.ac.jp/1828/00000320/
http://id.nii.ac.jp/1828/00000320/
Autor:
Thomas W, Stief
Publikováno v:
Drug Target Insights
Background The contact phase of coagulation is of physiologic/pathophysiologic importance, whenever unphysiologic polynegative substances such as cell fragments (microparticles) get in contact with blood. There are several clinically used inhibitors
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a635dfd48f2cd97cd70cfb98a86c3905
https://pubmed.ncbi.nlm.nih.gov/21901053
https://pubmed.ncbi.nlm.nih.gov/21901053
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.